Emerging Growth Conference 77

December 4 & 5, 2024

Agenda Wednesday December 4, 2024

ATRenew Inc. (NYSE: RERE) operates a leading technology-driven pre-owned consumer electronics transactions and services platform in China under the brand ATRenew. 

Keynote speakers: Jessie Jin, Investor Relations Manager, & Jeremy Ji, Director of Corporate Development & Investor Relations

Beneficient (NASDAQ: BENF) is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors and General Partners seeking exit options, anchor commitments and valued-added services for their funds with solutions that could help them unlock the value in their alternative assets.

Keynote speaker: Brad K. Heppner, CEO

U.S. Energy Corporation (NASDAQ: USEG) is a growth company focused on consolidating high-quality producing assets in the United States with the potential to optimize production and generate free cash flow through low-risk development while maintaining an attractive shareholder returns program. 

Keynote speaker: Ryan Smith, President, CEO & Director

Brenmiller Energy, Ltd. (NASDAQ: BNRG) helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller’s patented bGen™ thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. 

Keynote speaker: Nir Brenmiller, COO

West Red Lake Gold Mines Ltd. (OTCQB: WRLGF) (TSXV: WRLG) is a mineral exploration company that is publicly traded and focused on advancing and developing its flagship Madsen Gold Mine and the associated 47 km2 highly prospective land package in the Red Lake district of Ontario.

Keynote Speaker: Gwen Preston, Vice President, Communications

Eloro Resources, Ltd. (OTCQX: ELRRF) (TSX: ELO) is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration

Luca Mining (OTCQX: LUCMF) (TSX-V: LUCA) (Frankfurt: Z68) is a diversified Canadian mining company with two 100%-owned producing mines within the prolific Sierra Madre mineralized belt in Mexico which hosts numerous producing and historic mines along its trend.

Keynote speaker: Dan Barnholden, CEO

Regen BioPharma Inc. (OTC Pink: RGBP) is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space.

Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

Viomi Technology Co., Ltd. (NASDAQ: VIOT) mission is “AI for Better Water,” utilizing AI technology to provide better drinking water solutions for households worldwide.

Keynote speakers: Claire Ji – IR & Finance, and Sam Yang, Head of Capital and Strategy

Realbotix Corp. (OTCQB: XBOTF) (TSXV: XBOT), transcending the barrier between man and machine, creates human-like, socially intelligent robots that improve the human experience through learning, connection and play. 

Keynote speaker: Andrew Kiguel Co-Founder, CEO

Icon Energy Corp. (NASDAQ: ICON) is an international shipping company that provides worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels.

Keynote speakers: Ismini Evangelia Panagiotidi, CEO, Chairwoman & Dennis Psachos, CFO

NurExone Biologic Inc. (OTCQB: NRXBF) (TSXV: NRX) is a Pharmaceutical Company that is developing a platform for biologically-guided exosome-based therapies to be delivered, non-invasively, to patients who have suffered Central Nervous System injuries. 

Keynote speaker: Dr. Lior Shaltiel, CEO

Pure Cycle Corporation (NASDAQ: PCYO) is a diversified land and water resource development company who possess a lucrative portfolio of land and water rights in the fastest growing sector of the Denver metropolitan area. 

Keynote speaker: Mark Harding, President

MetaVia, Inc. (NASDAQ: MTVA) is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases.

Keynote speakers: Hyung Heon “HH” Kim, President / CEO, & Marshall H. Woodworth, CFO

Aethlon Medical, Inc. (NASDAQ: AEMD) is a medical therapeutic company focused on developing the Hemopurifier, a clinical stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. 

Keynote speakers: Jim Frakes, Acting CEO and CFO & Steven LaRosa, Chief Medical Officer

Sky Harbour Group Corporation (NYSE American: SKYH) is an aviation infrastructure company developing the first nationwide network of Home-Basing campuses for business aircraft. 

Keynote speakers: Tal Keinan, Founder and CEO & Francisco X. Gonzalez, CFO

Agenda Thursday December 5, 2024

U Power Limited (NASDAQ: UCAR) is a vehicle sourcing services provider, with a vision to becoming an EV market player primarily focused on its proprietary battery-swapping technology, or UOTTA technology, which is an intelligent modular battery-swapping technology designed to provide a comprehensive battery power solution for EVs. 

Keynote speaker: Paul Li, UCAR European Representative

BioVaxys Technology Corp. (OTCQB: BVAXF) (CSE: BIOV) is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on its DPX™ immune-educating technology platform and its HapTenix© “neoantigen” tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological diseases. 

Keynote speaker: James Passin, CEO

ASP Isotopes Inc. (NASDAQ: ASPI) is a pre-commercial stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries.

Keynote speaker: Paul Elliot Mann, CEO

Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain.

Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

Windtree Therapeutics, Inc. (NASDAQ: WINT) is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. 

Keynote speaker: Eric Curtis, COO and SVP

Longeveron, Inc. (NASDAQ: LGVN) is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. 

Keynote speaker: Mohamed Wa’el Hashad, CEO & Director

Bioxytran, Inc. (OTCQB: BIXT) is a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in virology, degenerative disease, and hypoxia. 

Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

Nova Minerals Limited (NASDAQ: NVA) (ASX: NVA) is a gold and critical minerals exploration and development company focused on advancing the Estelle Gold Project, comprised of 513 km2 of State of Alaska mining claims, which contains multiple mining complexes across a 35 km long mineralized corridor of over 20 identified gold prospects, including two already defined multi-million ounce resources across four deposits.

Keynote speaker: Christopher Gerteisen – CEO & Executive Director

Innovotech, Inc. (TSXV: IOT) is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology.

Keynote speaker: Craig Milne, CEO

Stuhini Explorations, Ltd. (OTCQB: STXPF) (TSXV: STU) is a mineral exploration company focused on exploration and development of precious and base metals properties in western Canada and the southwest United States. 

Keynote speaker: David O’Brien, President & CEO

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly delivered to patients from inventory. 

Keynote speaker: Jason Awe, Head of Corporate Communications & IR

Vista Gold Corp. (NYSE American: VGZ) (TSX: VGZ) holds the Mt Todd gold project, an advanced development-stage gold deposit located in the low risk, Tier-1 mining friendly jurisdiction of Northern Territory, Australia.

Keynote speaker: Frederick Earnest – CEO

Interstellar Communication Holdings provides an affordable personal satellite service named icMercury for stargazers, utilizing Pocketqube technology and a customized user platform. With this service, users can access their personal satellite and unlock the potential of the universe.

Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard  of IcMercury, and Lijie Zhu, Captain of icMercury

Cannabis Bioscience International Holdings Inc. (OTC Pink: CBIH) is a Houston-based publicly traded company listed on the OTC Markets under the ticker symbol CBIH. At CBIH, we specialize in therapeutic clinical research and the advancement of professionalism within the medical cannabinoid industry through extensive education and research on the plant’s molecular compounds: www.cbih.net. The company has developed a diverse range of medical formulations harnessing the therapeutic potential of cannabinoids to address ailments such as cancer, shingles, PTSD, epilepsy, anxiety, and more.

Keynote speakers: Dante Picaso, President / CEO

Opawica Explorations Inc. (OTCQB: OPWEF) (TSXV: OPW) is a junior Canadian exploration company with a strong portfolio of precious and base metal properties within the Rouyn-Noranda region of the Abitibi Gold Belt in Qubec. 

Keynote speaker: Blake Morgan, President / CEO

The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.

Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.

The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.